Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomarkers in Alzheimer Disease and Other Dementias: What’s Next into Pathophysiology to Support Clinical Practice and Drug Development

Published:2022-09-30 Issue:10 Volume:58 Page:1374
ISSN:1648-9144
Container-title:Medicina
language:en
Short-container-title:Medicina

Author:

Bougea Anastasia^ORCID

Abstract

Neurodegenerative diseases are a heterogeneous group of disorders characterized by gradual progressive neuronal loss in the central nervous system [...]

Publisher

MDPI AG

Subject

General Medicine

Link

https://www.mdpi.com/1648-9144/58/10/1374/pdf

Reference10 articles.

1. The global burden of neurological disorders

2. Synuclein in neurodegeneration;Bougea;Adv. Clin. Chem.,2021

3. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

4. Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study

5. Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP